Skip to main content

Grafa News and Videos — Page 1467

Latest

Grafa

Nanobiotix Nanoprimer enhances LNP-DNA delivery, reduces liver toxicity in preclinical trials

Nanobiotix (NASDAQ:NBTX), a late-clinical stage biotechnology company, announced the presentation of new preclinical data today at the 2026 Annual Meeting of the American Association for Cancer Research (AACR).

Read more: Nanobiotix Nanoprimer enhances LNP-DNA delivery, reduces liver toxicity in preclinical trials

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift